Deleted in liver cancer-1 (DLC-1): A tumor suppressor not just for liver
- 20 April 2007
- journal article
- review article
- Published by Elsevier
- Vol. 40 (5) , 843-847
- https://doi.org/10.1016/j.biocel.2007.04.008
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell linesCancer Detection Prevention, 2007
- DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinomaBiochemical and Biophysical Research Communications, 2007
- The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1The Journal of cell biology, 2006
- Aberrant Methylation and Deacetylation of Deleted in Liver Cancer-1 Gene in Prostate Cancer: Potential Clinical ApplicationsClinical Cancer Research, 2006
- High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myelomaJournal of Clinical Pathology, 2006
- Mitochondrial targeting of growth suppressor protein DLC2 through the START domainFEBS Letters, 2005
- The RhoGAP Protein DLC-1 Functions as a Metastasis Suppressor in Breast Cancer CellsCancer Research, 2005
- DLC‐1, a Rho GTPase‐activating protein with tumor suppressor function, is essential for embryonic developmentFEBS Letters, 2005
- Analysis of DLC-1 expression in human breast cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2003
- Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancersCancer Genetics and Cytogenetics, 2003